Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2

Sakref, Candice; Saby, Alexis; Rodriguez, Celine; Ardin, Maude; Moudombi, Lyvia; Doffin, Anne-Claire; Gobbini, Elisa; Voissiere, Aurelien; Besson, Laurie; Laoubi, Leo; Boettcher, Jan; Depil, Stephane; Hubert, Margaux; Bendriss-Vermare, Nathalie; Caux, Christophe; Valladeau-Guilemond, Jenny

dc.contributor.author	Böttcher, Jan
dc.date.accessioned	2026-03-20T09:33:17Z
dc.date.available	2026-03-20T09:33:17Z
dc.date.issued	2025
dc.identifier.issn	2041-1723
dc.identifier.uri	http://hdl.handle.net/10900/177229
dc.language.iso	en	en
dc.publisher	Berlin : Nature Portfolio	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41467-025-58220-8
dc.subject.ddc	500	de_DE
dc.title	Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_01128
utue.personen.roh	Sakref, Candice
utue.personen.roh	Saby, Alexis
utue.personen.roh	Rodriguez, Celine
utue.personen.roh	Ardin, Maude
utue.personen.roh	Moudombi, Lyvia
utue.personen.roh	Doffin, Anne-Claire
utue.personen.roh	Gobbini, Elisa
utue.personen.roh	Voissiere, Aurelien
utue.personen.roh	Besson, Laurie
utue.personen.roh	Laoubi, Leo
utue.personen.roh	Boettcher, Jan
utue.personen.roh	Depil, Stephane
utue.personen.roh	Hubert, Margaux
utue.personen.roh	Bendriss-Vermare, Nathalie
utue.personen.roh	Caux, Christophe
utue.personen.roh	Valladeau-Guilemond, Jenny
dcterms.isPartOf.ZSTitelID	Nature Communications	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	16	de_DE
utue.fakultaet	04 Medizinische Fakultät